Peds Flashcards
(73 cards)
What are favorable sites
orbit, non-para h&n, non-bladder/prostate GU, billiary (bong)
What are non-parameningeal sites
larynx, soft tissues, salivary glands,
Group I rhabdo
completely resected
Group IIA rhabdo
microscopic positive margin
Group IIB rhabdo,
grossly resected LN disease
Group IIC rhabdo
IIA + IIB, positive margin and LN
Group III rhabdo
Gross residual disease
Group IV rhabdo
DM
Stage I rhabdo
favorable site
Stage II rhabdo
unfav site <=5 cm and LN-
Stage III rhabdo
unfav site >5 cm or LN+
Stage IV rhabdo
DM
Low risk rhabdo
fox-1 negative and Group I-III fav site or Group I-II unfav site
Intermediate risk rhabdo
Every Alveolar and Group III of unfav site, and Group IV age<10 embryonal
high risk rhabdo
All Group IV except for Age<10 embryonal
Path needed for rhabdo
primary site biopsy, BM biopsy, CSF if parameningeal, SLNB if extremity
Management of low risk rhabdo
VACx24 w with RT at week 12
Management of intermediate risk rhabdo
VAC/VIx42w, RT at week 12
Management of high risk rhabdo
VAC/IE x54w, Primary RT at week 20, DM RT after CHT
Dose for primary site RT for rhabdo Group 1
Embryonal: 0 Gy, Alveolar: 36 Gy
Dose for primary site RT for rhabdo Group II
IIA: 36 Gy, IIB: 41.4 Gy (draining lymphatic chain receives 36 Gy)
Rhabdo Orbit PR dose
50.4 Gy
Rhabdo Orbit CR dose
45 Gy
Dose for primary site RT for rhabdo Group III
<5 cm: 5040, >5 cm: 5940 cGY